thioctic acid has been researched along with Dyskinesia, Medication-Induced in 3 studies
Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic use of (-)-15 reduced L-DOPA-induced dyskinesia (LID) without attenuating the antiparkinsonian effect." | 1.37 | Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile. ( Gao, B; Guo, L; Liu, Z; Ye, N; Zhang, A; Zhang, H; Zhen, X; Zheng, L; Zhou, S, 2011) |
| "Haloperidol (HAL) is a widely used neuroleptic drug for the treatment of acute and chronic psychosis." | 1.35 | Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats. ( Himabindhu, G; Thaakur, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, SF | 1 |
| Xie, CL | 1 |
| Lin, JY | 1 |
| Wang, MH | 1 |
| Wang, XJ | 1 |
| Liu, ZG | 1 |
| Thaakur, S | 1 |
| Himabindhu, G | 1 |
| Zhang, H | 1 |
| Ye, N | 1 |
| Zhou, S | 1 |
| Guo, L | 1 |
| Zheng, L | 1 |
| Liu, Z | 1 |
| Gao, B | 1 |
| Zhen, X | 1 |
| Zhang, A | 1 |
3 other studies available for thioctic acid and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Lipoic acid alleviates L‑DOPA‑induced dyskinesia in 6‑OHDA parkinsonian rats via anti‑oxidative stress.
Topics: Animals; Antioxidants; Caspase 3; Disease Models, Animal; Dopaminergic Neurons; Dyskinesia, Drug-Ind | 2018 |
Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats.
Topics: Animals; Antioxidants; Antipsychotic Agents; Brain; Catalepsy; Dose-Response Relationship, Drug; Dys | 2009 |
Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.
Topics: Animals; Antiparkinson Agents; Aporphines; Binding, Competitive; CHO Cells; Corpus Striatum; Criceti | 2011 |